Prostaglandins and Other Lipid Mediators

Aims & Scope

Prostaglandins & Other Lipid Mediators is the original and foremost journal dealing with prostaglandins and related lipid mediator substances.

It includes basic and clinical studies related to the pharmacology, physiology, pathology and biochemistry of lipid mediators.

Prostaglandins & Other Lipid Mediators invites reports of original research, mini-reviews, reviews, and methods articles in the basic and clinical aspects of all areas of lipid mediator research: cell biology, developmental biology, genetics, molecular biology, chemistry, biochemistry, physiology, pharmacology, endocrinology, biology, the medical sciences, and epidemiology.

Prostaglandins & Other Lipid Mediators also accepts proposals for special issue topics.

The Editors will make every effort to advise authors of the decision on the submitted manuscript within 3-4 weeks of receipt.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.5

SJR (SCImago Journal Rank)

Year	Value
2024	0.699

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	89

Journal Rank

Year	Value
2024	8124

Journal Citation Indicator

Year	Value
2024	365

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Phospholipase A2 enzymes

  Citation: 580

  Authors: Ichiro, Makoto

• The cannabinoid receptors

  Citation: 375

  Authors: Allyn C

• Distinct functions of COX-1 and COX-2

  Citation: 341

  Authors: Ikuo

• Cyclooxygenase isozymes and their gene structures and expression

  Citation: 317

  Authors: Tadashi, Norimitsu

• Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance

  Citation: 308

  Authors: Mu-En, Deron R., Jerold

• Regulation of inflammation in cancer by eicosanoids

  Citation: 252

  Authors: Emily R., Sui, Charles N., Dipak

• Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis

  Citation: 250

  Authors: Charles N, Katherine, Song, Makoto

• Prostaglandin catabolizing enzymes

  Citation: 246

  Authors: Hsin-Hsiung, Charles Mark, Min, Huiping, Fengxiang

• Omega-3 fatty acids and their lipid mediators: Towards an understanding of resolvin and protectin formation

  Citation: 220

  Authors: Karsten H., Cheng-Ying, Beate, Simon F., Bertram

• Prostaglandin E synthase

  Citation: 208

  Authors: Makoto, Yoshihito, Toshihiro, Ichiro

---